نسبة انتشار المتلازمة الأيضية بين الأشخاص المترددين على العيادة المجمعة بمنطقة القرضة الشاطئ وعلاقتها بالجنس والعمر

[1]-Saklayen, M.G., The global epidemic of the metabolic syndrome.Current hypertension reports, 2018. 20(2): p. 1-8.

[2]-Pammer, L.M., et al., Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort.Journal of Internal Medicine, 2021. 290(6): p. 1219-1232.

[3]-Swarup, S., etal., Metabolic syndrome.StatPearls

[internet], 2021.

[4]-Wang, H.H., et al., Novel insights into the pathogenesis and management of the metabolic syndrome.PediatricGastroenterology, Hepatology & Nutrition, 2020. 23(3): p. 189.

[5]-Anagnostis, P., et al., The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis.The Journal of Clinical Endocrinology & Metabolism, 2009. 94(8): p. 2692-2701.

[6]-Garcez ,A., et al., Basal cortisol levels and metabolic syndrome: A systematic review and meta-analysis ofobservational studies.Psychoneuroendocrinology, 2018. 95: p. 50-62.

[7]-Reisinger, C., Nkeh-Chungag, B. N., Fredriksen, P. M., & Goswami, N. (2021). The prevalence of pediatric metabolic syndrome—A critical look on the discrepancies between definitions and its clinical importance.International Journal of Obesity,45(1), 12-24.

[8]-García‐Jiménez, S., Bernal Fernandez, G., Martinez Salazar, M. F., Monroy Noyola, A., Toledano Jaimes, C., Meneses Acosta, A., ... & Sánchez‐Alemán, M. A. (2015). Serum leptin is associated with metabolic syndrome in obese Mexican subjects.Journal of clinical laboratory analysis,29(1), 5-9.

[9]-Sinclair, A. J., Dunning, T., Mañas, L. R., & Munshi, M. (Eds.). (2017).Diabetes in old age.John Wiley & Sons.

[10]-Laakso, M. and P.T. Kovanen, Metabolic syndrome: To be or not to be?Annals of medicine, 2006. 38(1): p. 32-33.

[11]-Hirode, G. and R.J. Wong, Trends in the prevalence of metabolic syndrome in the United States, 2011-2016.Jama, 2020. 323(24): p. 2526-2528.

[12]-Delavari, A., Forouzanfar, M. H., Alikhani, S., Sharifian, A., & Kelishadi, R. (2009). First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran.Diabetes care,32(6), 1092-1097

[13]-Rochlani, Y., Pothineni, N. V., Kovelamudi, S., & Mehta, J. L. (2017). Metabolic syndrome: pathophysiology, management, and modulation by natural compounds.Therapeutic advances in cardiovascular disease,11(8), 215-225.

[14]-O'Neill, S. and L. O'Driscoll, Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies.Obesity reviews, 2015. 16(1): p. 1-12.

[15]-Hajat ,C. and Z. Shather, Prevalence of metabolic syndrome and prediction of diabetes using IDF versus ATPIII criteria in a Middle East population.Diabetes research and clinical practice, 2012. 98(3): p. 481-486.

[16]-Al-Qahtani, D.A. and M.L. Imtiaz, Prevalenceof metabolic syndrome in Saudi adult soldiers.Saudi medical journal, 2005. 26(9): p. 1360-1366.

[17]-Ali, N.S., A.K. Khuwaja, and K. Nanji, Retrospective analysis of metabolic syndrome: Prevalence and distribution in executive population in urban Pakistan.International journal of family medicine, 2012. 2012.

[18]-Nikbakht, H.-A., et al., Prevalence of metabolic syndrome and its components among a population-based study in south of ran, PERSIAN Kharameh cohort study.Clinical Epidemiology and Global Health, 2020. 8(3): p. 678-683.

[19]-Liang, X., et al., Prevalenceof Metabolic Syndrome in the United States National Health and Nutrition Examination Survey (NHANES) 2011-2018.medRxiv, 2021.

[20]-Ebrahimi, H., et al., Metabolic syndrome and its risk factorsamong middle aged population of Iran, a population based study.Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2016. 10(1): p. 19-22.

[21]-Hajian-Tilaki, K., et al., Prevalence of metabolic syndrome and the association with socio-demographic characteristics and physical activity in urban population of Iranian adults: a population-based study.Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2014. 8(3): p. 170-176.

[22]-Mokhayeri, Y., et al., Metabolic syndrome prevalence in the Iranian adult’s general population and its trend: a systematic review and meta-analysis of observational studies.Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2018. 12(3): p. 441-453.

[23]-Al-Rubeaan, K., Bawazeer, N., Al Farsi, Y., Youssef, A. M., Al-Yahya, A. A., AlQumaidi, H., ... & Al Rumaih, F. I. (2018). Prevalence of metabolic syndrome in Saudi Arabia-a cross sectional study.BMC endocrine disorders,18(1), 1-9.

[24]-Sarrafzadegan, N., et al., Metabolic syndrome in Iranianelderly.ARYA atherosclerosis, 2012. 7(4): p. 157.

[25]-Kuzuya, M., et al., Age-specific change of prevalence of metabolic syndrome: longitudinal observation of large Japanese cohort.Atherosclerosis, 2007. 191(2): p. 305-312.

[26]-Bruno, G., et al., Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study.Diabetes care, 2004. 27(11): p. 2689-2694.

[27]-O'Neill, S. and L. O'Driscoll, Metabolic syndrome: a closer look at the growing epidemicand its associated pathologies.Obes Rev, 2015. 16(1): p. 1-12.

[28]-Welty, F.K., A. Alfaddagh, and T.K. Elajami,Targeting inflammation in metabolic syndrome.Translational research : the journal of laboratory and clinical medicine, 2016. 167(1): p. 257-280.

[29]-Prior, J.O., et al., Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus.Circulation, 2005. 111(18): p. 2291-8.

[30]-Eckel, R.H., et al., The metabolic syndrome.The lancet, 2010. 375(9710 :)p. 181-183.